The Collaborative for Effective Prescription Opioid Policies (CEPOP) recently announced CEPOP Salutes – a series of awards to recognize and highlight the good work of individuals and organizations across the array of stakeholders in the comprehensive response to opioid abuse, misuse, and diversion. There will be a WebEx webinar on August 15, 2016 at 1:00[…]
CEPOP is proud to announce a series of awards to recognize and highlight the good work of individuals and organizations in the comprehensive response to opioid abuse, misuse, and diversion.
All CEPOP participants are invited to a statewide event in Nashville co-hosted by axialHealthcare and CEPOP to discuss solutions to the opioid abuse challenges facing that region. A draft agenda is attached. For more information on how to participate, please contact John Donahue at email@example.com.
Last month, CEPOP members sent a letter (click here) to the Missouri legislature, showing support for the enactment of a state prescription drug monitoring program (PDMP) and offering suggestions for legislation: • Implement technological improvements to facilitate secure access to the PDMP through electronic health information systems as expeditiously as possible; • Allow for record retention[…]
Dear Chairman Grassley and Ranking Member Leahy: The Collaborative for Effective Prescription Opioid Policies (CEPOP) involves over 60 diverse organizations working toward a comprehensive and balanced policy strategy to reduce prescription opioid abuse and promote treatment options. The undersigned members of CEPOP are writing to encourage the Committee’s action on S. 524, the Comprehensive Addiction[…]
WASHINGTON, D.C. (February 9, 2016) – The Collaborative for Effective Prescription Opioid Policies (CEPOP) today commends President Obama for his proposal to address prescription drug misuse in his Fiscal Year 2017 Budget. CEPOP also calls for additional action including appointing a leader for this effort, investing in prevention, and increasing access to rescue medications to reverse[…]
Recently, CEPOP led an advocacy campaign to support strategic funding to help battle opioid abuse in the Omnibus Appropriations legislation. That effort was supported by 19 organizations. To read the funding letter sent to the Committee on Appropriations, please click here.
Over 50 participants attended a congressional briefing to learn how new therapies, precision medicine, big data, and disposal technologies are helping in the effort to stem this epidemic. Congressman Ami Bera, MD provided views on the policy efforts which are needed from his perspective as both a physician and lawmaker. (From left to right: Gen.[…]
Join CEPOP on Thursday, December 3 at the Capitol Visitors Center to learn how precision medicine, big data, disposal technology, new therapies, and other innovative approaches are helping to confront the opioid abuse epidemic. The lunch is from 11:30 to 1 p.m. The full invitation can be found here.
CEPOP issued the attached press release (CEPOP October 2015 Press Release White House Action) commending the White House for its efforts to address the ongoing opioid epidemic as well as its recognition of private sector efforts to do the same.
CEPOP co-founder Mary Bono sat down with House Energy & Commerce Committee Chairman Upton to discuss the current policy landscape surrounding prescription opioid abuse. The meeting came as the E&C Health Subcommittee was reviewing several legislative proposals to address different dimensions of the epidemic.
CEPOP Participants Meet with CDC Director Frieden on FY 2017 Agency Plan and Proposed Prescription Guidelines
Last month, CEPOP members met with CDC Director Dr. Tom Frieden to discuss the agency’s unfolding FY 2017 initiatives, and to learn more about the CDC’s draft guidelines for prescribing opioids for chronic pain. CEPOP will continue advocacy for the final FY 2017 appropriations and will develop comments on the proposed guidelines.
October issue, the JAMA published a series of articles on the growing opioid epidemic, demonstrating the range issues facing the medical community and policymakers. The articles included Addressing the Opioid Epidemic, Changes in Substance Abuse Treatment Use, and Nonmedical Prescription Opioid Use.
This month, AIT celebrated 25 years of leadership in toxicology testing and patient prescription drug monitoring. In 2014, AIT introduced GuideMed, a service that assists health care providers as they build monitoring programs that are both effective and ethical.
In a recent study, researchers found a correlation between Florida’s Prescription Drug Monitoring Program (PDMP) and pill mill laws and a decrease in opioid prescribing and use, particularly among patients with the highest levels of use.
House Passes H.R. 1725 – National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015
The House yesterday also passed the National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015, which would reauthorize funding for states to operate and expand their controlled substance monitoring programs.
The House yesterday passed the Protecting Our Infants Act of 2015, which now moves on to the Senate for consideration. Sponsored by Rep. Katherine Clark (MA-D-5), this bill would mandate an evaluation of the rise of prenatal opioid abuse and neonatal abstinence syndrome and include recommendations for prevention and treatment.
House Energy & Commerce Committee Democrats wrote to U.S. FDA Commissioner Ostroff requesting his agency require opioid manufacturers to revise their product labels to reflect concerns surrounding neonatal abstinence syndrome. The letter was signed by 22 members.
Prior to the August recess, Sens. Cassidy (R-LA) and Murphy (D-CT) introduced the Mental Health Reform Act of 2015. The legislation seeks to make numerous reforms surrounding the mental healthcare system, including the establishment of an Assistant Secretary for Mental Health and Substance Use Disorders within the U.S. Department of Health and Human Services.
Last month, the National Governors Association (NGA) held their annual summer meeting in West Virginia to discuss critical issues facing states. The nation’s opioid crisis took center stage with various experts speaking on the epidemic. Video from that session can be found here.
The National Governor’s Association held their summer meeting in West Virginia over the weekend. Honorable Mary Bono spoke before the group about the opioid abuse epidemic and invited them to join forces with CEPOP. The weekend-long meeting drew to a close with good news: HHS Secretary Sylvia Burwell announced that her agency would devote an additional $100 million to[…]
New DEA Administrator Chuck Rosenberg announced that the agency would be reviving the national drug take-back initiative. The decision comes as Chief Rosenberg has learned, over the course of two months, the true extent of the opioid abuse epidemic: “I knew there was a problem. I knew it was big. I didn’t know it was[…]
Grünenthal Group, a pharmaceutical company based in Germany, announced a collaboration with Proteus S.A., a Chilean company, and Boston Children’s Hospital on the anesthetic neosaxitoxin. Neosaxitoxin is a novel anesthetic used for local anesthesia and post-operative pain management.
The American Society of Addiction Medicine released its National Practices Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use. The guidelines are meant to assist physicians in treating patients with addiction issues.
Hazelden Betty Ford Foundation announced the results of its survey on prescription opioid use among young people at an event on Capitol Hill that featured several legislators who have led on these issues. The survey addresses both usage and whether young people know where to turn for help. The entire event can be viewed on their website.
On June 10th, USA Today published an op-ed authored by Gen. Dean of Community Anti-Drug Coalitions of America, Jeffrey Levi of Trust for America’s Health and the Honorable Mary Bono. The column introduces CEPOP and explains why a collaborative approach is necessary to address these issues.
The Patient-Centered Outcomes Research Institute will be hosting a stakeholder workshop on Tuesday, June 9 from 9am – 5pm at the Grand Hyatt in Washington, D.C. The purpose of the workshop will be to discuss whether comparative clinical effectiveness research (CER) can help to answer questions surrounding long-term use of opioids. More information, including registration can[…]
Senators Manchin (D-WV) and Scott (R-SC) officially launched the Senate Prescription Drug Abuse Caucus. The effort is the latest activity to raise awareness surrounding the damage being caused by prescription drug abuse. The new Caucus pledges to engage stakeholders to find innovative and effective policy solutions to address the issue and notes that, “With 46 Americans dying every[…]
Congressional Addiction Forum – Advancing Prevention, Treatment, and Recovery for Youth – Wednesday, April 29, 2015 from 9:30am to 12:30pm
The Congressional Addiction Forum – Advancing Prevention, Treatment, and Recovery for Youth – will be held on Wednesday, April 29, 2015 from 9:30am to 12:30pm on Capitol Hill. Key stakeholders and policy makers will be convening to help guide consensus and discuss best practices on addiction and youth. At the forum, attendees will help identify[…]
House Energy & Commerce Subcommittee on Oversights & Investigation announces April 23 hearing: Combatting the Opioid Abuse Epidemic: Professional and Academic Perspectives
The House Energy & Commerce Subcommittee on Oversight & Investigations has announced it will hold a hearing on April 23 entitled, “Combatting the Opioid Abuse Epidemic: Professional and Academic Perspectives.” The hearing will be an opportunity for Members to solicit perspectives on treatment options currently available and new evidence-based practices for supporting individuals living with addiction.
The Collaborative for Effective Prescription Opioid Policies (CEPOP) will hold an introductory open house April 8 at the National Rx Drug Abuse Summit in Atlanta, Georgia. Lunch and refreshments will be provided at the event, to be held 11:30 a.m. to 1:30 p.m. in Ansley 6 on the sixth floor of the Westin Peachtree Plaza. The[…]
The Collaborative for Effective Prescription Opioid Policies will attend the National Rx Drug Abuse Summit in Atlanta, Georgia, April 6-9, 2015. The event is the largest national collaboration of professionals from local, state and federal agencies, business, academia, clinicians, treatment providers, counselors, educators, state and national leaders, and advocates impacted by Rx drug abuse. Event[…]
WASHINGTON, D.C.. (March 27, 2015) – The Collaborative for Effective Prescription Opioid Policies (CEPOP) provided a ringing endorsement today for new actions to confront the opioid abuse epidemic announced March 26 by Health and Human Services Secretary Sylvia M. Burwell. The Administration’s initiative includes new funding to support health professional decision-making, the use of naloxone[…]